Physician profile
Bryan X Lee
NPI 1467512624
$2,138.03
in general payments reported to CMS, 2019-2025
12 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2021: $176 · 2022: $30.87 · 2023: $761 · 2024: $574 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935 · Travel and Lodging: $647 · Education: $32.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.57 |
| Travel and Lodging | $647.16 |
| Education | $32.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $792.23 | 2022-2023 | Nalu Neurostimulation System |
| Curonix LLC | $259.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $249.94 | 2024-2025 | |
| Globus Medical, INC. | $174.01 | 2019 | |
| Abbott Laboratories | $173.21 | 2019-2021 | |
| Medtronic, INC. | $140.00 | 2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Lilly USA, LLC | $128.08 | 2019-2024 | Mounjaro |
| Pacira Pharmaceuticals Incorporated | $101.23 | 2024 | Iovera |
| Depuy Synthes Sales INC. | $63.62 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $22.82 | 2019 | |
| Bioventus LLC | $18.60 | 2019 | |
| Stryker Corporation | $14.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.